Literature DB >> 12546592

Vibrational angioplasty in the treatment of chronic infrapopliteal arterial occlusions: preliminary experience.

Dimitrios K Tsetis1, Lampros K Michalis, Michael R Rees, Asterios N Katsamouris, Miltiadis I Matsagas, Christos S Katsouras, Dimitrios A Sideris, Nicholas C Gourtsoyiannis.   

Abstract

PURPOSE: To evaluate the safety and efficacy of vibrational angioplasty in chronic infrapopliteal arterial occlusions.
METHODS: Twelve patients (9 men, aged 54 to 90 years) with 13 below-knee arterial chronic total occlusions were treated percutaneously using vibrational angioplasty. The occlusions were located in the anterior tibial artery (n=5), the tibioperoneal trunk (n=4), the peroneal artery (n=1), the posterior tibial artery (n=1), and in both the tibioperoneal trunk and peroneal artery (n=2). The length of the lesions ranged from 5 to 14 cm.
RESULTS: Recanalization was successful in 12 (92.3%) lesions. In 1 case, the wire perforated the arterial wall; the procedure was abandoned without clinical sequelae. The time to cross the occlusions with the wire ranged from 6 to 19 minutes. No other complications were observed. Clinical follow-up ranged to 18 months. Ten patients with ulceration or gangrene demonstrated good wound healing, and pain was alleviated in all successfully treated patients.
CONCLUSIONS: Vibrational angioplasty appears feasible as a means of safely recanalizing chronic total occlusions of the infrapopliteal arteries. Further experience should be acquired to assess its short- and long-term effects on this vascular territory.

Entities:  

Mesh:

Year:  2002        PMID: 12546592     DOI: 10.1177/152660280200900624

Source DB:  PubMed          Journal:  J Endovasc Ther        ISSN: 1526-6028            Impact factor:   3.487


  1 in total

1.  Surgical treatment of lower limb ischemia in diabetic patients - long-term results.

Authors:  Bekir Inan; Unal Aydin; Murat Ugurlucan; Cemalettin Aydin; Melike Elif Teker
Journal:  Arch Med Sci       Date:  2013-12-18       Impact factor: 3.318

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.